Log in
Enquire now
‌

US Patent 9597332 Sulfide alkyl compounds for HBV treatment

Patent 9597332 was granted and assigned to Novira Therapeutics on March, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Currently, there are no issues on this topic.

Find more entities like US Patent 9597332 Sulfide alkyl compounds for HBV treatment

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.